Q1 2026 TU
Logotype for Hiscox Ltd

Hiscox (HSX) Q1 2026 TU earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Hiscox Ltd

Q1 2026 TU earnings summary

7 May, 2026

Executive summary

  • Group insurance contract written premiums (ICWP) rose 10.2% year-over-year to over $1.7 billion, with strong momentum in Retail and disciplined growth in big-ticket segments.

  • Retail ICWP increased by 15.1% (8.0% in constant currency), with growth accelerating across all businesses, supported by management actions, distribution, and specialty initiatives.

  • Big ticket growth was selective, focusing on favorable lines and new business initiatives amid a softening market.

  • Loss experience was within expectations, with benign natural catastrophe activity offsetting Middle East conflict impacts.

  • Operational efficiencies advanced through a change programme, including outsourcing financial processes and consolidating IT services.

Financial highlights

  • Investment result for Q1 2026 was $34.1 million (0.4% return), impacted by $69.6 million in unrealised fair value losses on fixed income securities.

  • Group invested assets totaled $9.3 billion at March 31, with a reinvestment yield of 4.4% and a two-year duration.

  • 94% of the investment portfolio is in cash and fixed income, with an average credit rating of 'A'.

  • Retail premiums grew 8% in constant currency, in line with full-year guidance, with modest 2% rate increases.

  • U.K. retail grew 8.9%, with art and private client achieving double-digit growth for the seventh consecutive quarter.

Outlook and guidance

  • Positive outlook for 2026, with focus on profitable growth and continued progress on operational change objectives.

  • Guidance maintained for full-year Retail ICWP growth, supported by ongoing distribution and specialty initiatives.

  • Combined ratio guidance for retail is 89%-94%, with expectations for margin improvement as the change program delivers.

  • Change programme expected to deliver $75 million P&L benefit in 2026 and $200 million annually by 2028.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Hiscox